Advenchen Pharmaceuticals, Llc.

This study tests an oral drug called AL8326 in people with advanced small cell lung cancer that has returned or spread after at least one prior treatment. The goal is to find the best dose and see if it can shrink tumors or slow cancer growth. About 36 adults with good performanc…